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Abstract
A key observation about the human immune response to repeated exposure to influenza A is that the first strain infecting
an individual apparently produces the strongest adaptive immune response. Although antibody titers measure that
response, the interpretation of titers to multiple strains – from the same sera – in terms of infection history is clouded by age
effects, cross reactivity and immune waning. From July to September 2009, we collected serum samples from 151 residents
of Guangdong Province, China, 7 to 81 years of age. Neutralization tests were performed against strains representing six
antigenic clusters of H3N2 influenza circulating between 1968 and 2008, and three recent locally circulating strains. Patterns
of neutralization titers were compared based on age at time of testing and age at time of the first isolation of each virus.
Neutralization titers were highest for H3N2 strains that circulated in an individual’s first decade of life (peaking at 7 years).
Further, across strains and ages at testing, statistical models strongly supported a pattern of titers declining smoothly with
age at the time a strain was first isolated. Those born 10 or more years after a strain emerged generally had undetectable
neutralization titers to that strain (,1:10). Among those over 60 at time of testing, titers tended to increase with age. The
observed pattern in H3N2 neutralization titers can be characterized as one of antigenic seniority: repeated exposure and the
immune response combine to produce antibody titers that are higher to more ‘senior’ strains encountered earlier in life.
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Introduction
It has long been know that humans have a higher serologic
response to stains of influenza strains early in their lives, even after
vaccination or exposure to more recent strains [1–3]. Consistent
with this phenomenon, some experimental studies in animals and
humans have shown that a second vaccine (or infection) boosts the
serological response to earlier infections and may result in a less
robust serological response itself [4–6]. However, there is some
question as to whether this apparent primacy of initial antibodies in
a first infection represents greater protection against similar strains
and reduced protection against later strains [7]. Little is known
about how the relationship between the antibody response to earlier
and later infections plays out in the complex patterns of influenza
infection and vaccination experienced by real populations. Under-
standing these patterns may aid in the interpretation of serological
evidence (i.e., seroepidemiology), and provide insight into how our
immune system interacts with an ever changing pathogen.
The concentration of antibodies associated with different
influenza strains is most often determined using the hemaggluti-
nation inhibition (HI) or viral neutralization (NT) assay [8].
However, the picture of historic influenza infections offered by
these assays is imperfect. Both HI and NT assays only measure the
ability of a person’s serum to interfere with the processes necessary
for viral replication, and do not distinguish between highly specific
and cross reactive antibodies [8]. Accurately characterizing how
antibody levels change over a lifetime of influenza exposure can
aid in the interpretation of serological assays and expand our
understanding of how the immune system responds to a complex
and ever changing pathogen.
Since they emerged in 1968, human influenza A H3N2 virus
strains have been in continual global circulation. During this time,
H3N2 strains have undergone continual genetic drift, with
genetically similar viruses predominating for one or two seasons
before receding [9]. Antigenic drift of these strains is thought to be
faster than genetic drift, characterized by clustering of strains
within antigenic space and occasional longer jumps to form new
clusters [10]. Seasonal H1N1 strains re-emerged in 1977,
developing their own sequential lineage, and continue to co-
circulate with H3N2 strains to the present [11]. Nonetheless,
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H3N2 strains represent a sustained lineage with rapid and regular
turn-over of genetically and antigenically distinct strains. As such,
they present an opportunity to explore the relationship between
the birth-year of individuals and their antibody response to key
strains, each of which represents a possible exposure or infection at
a different time in an individual’s life. While it may not be possible
to know exactly which strains each individual was infected with,
the combination of titer and age may give us some insight into
each individual’s history of infection. Across an entire population,
the relationship between age of potential infection and titer may
reveal patterns that increase our understanding of influenza
biology and our ability to interpret serological surveys.
Here we characterize the serologic profiles to historic strains of
H3N2 influenza in a population from Guangdong province,
China. We develop a statistical model characterizing the
relationship between age and neutralization titers to strains of
H3N2 influenza circulating from 1968–2008. We propose a
refinement of the original antigenic sin hypothesis, antigenic
seniority, which may better explain the patterns of immune
response seen in this population.
Results
Participant recruitment
Of 273 participants interviewed, 151 provided serum and were
tested for H3N2 antibodies. Samples were more often from adults
than children (Table 1). Age at time of testing ranged from 7 to 81
years of age. Age at time of strain isolation ranged from 34 years
before birth (for A/Hong Kong/1968 (H3N2)) to 80 years of age
(for A/Shantou/2008 (H3N2)).
Description of titers
A total of 1,359 (9 strains|151 individuals) neutralization tests
were performed. While peak neutralization titer varied by strain,
age-specific mean log-neutralization titers (estimated from a
smoothing spline) were consistently highest among those who were
in the first decade of life at the time when a given strain was isolated
(Figure 1, S1). When we compare the mean log-neutralization titer
of all those in a given birth cohort to a given strain, we see that the
highest titers for a given strain occur in among the youngest birth
cohort alive when that strain was isolated and declines for
progressively older cohorts (Figure 2A), and that a birth cohort’s
titer is highest relative to other birth cohorts for the strains isolated
when they were youngest, and declines smoothly for strains isolated
later (Figure 2B). In all strains we observe smoothly declining mean
titers with increasing age at time of circulation until we reach that
cohort of individuals who were 60 or older at the time of sample
collection. For those aged 60 and older at the time of sample
collection we observe a smooth increase in mean titers with age,
seemingly regardless of strain (Figure 1). Those not yet born at the
time of strain isolation show the lowest titers to every strain, with
most born 10 years or more after strain isolation having
neutralization titers below the detectable threshold (,1:10). For
example, against A/Beijing/1989 (H3N2) all those born 10 or more
years after 1989 have undetectable titers, those born 0–9 years after
1989 mean log titer of 3.1 (95% CI: 2.3,3.9), those aged 0–9 in 1989
have mean log titers of 4.5 (95% CI: 3.9, 5.0), those aged 10–19 in
1989 have mean log titers of 3.4 (95%CI: 2.9, 3.8), those 20 or older
in 1989 but under 70 in 2009 have mean log titers of 2.4 (95% CI:
2.1, 2.6) and those 70 or older in 2009 have mean log titers of 2.7
(95% CI: 2.2, 3.3) (Figure S1).
Comparison of statistical models of age and titer
We find evidence supporting a strain independent relationship
between log neutralization titers, age at time of strain isolation and
Table 1. Demographics and history of vaccination and recent
illness among study participants.
Provided Sample?
Yes N(%) No N(%) p Total N(%)
Total 151 122 273
Sex
Male 82 (54) 58 (48) 0.30 140 (51)
Female 69 (46) 63 (52) 132 (48)
Age in years
,10 5 (3) 16 (13) 0.03 21 (8)
10–19 16 (11) 11 (9) 7(10)
20–29 20 (13) 11 (9) 31(11)
30–39 24(16) 19(16) 43(16)
40–49 26(17) 9(7) 35(13)
50–59 27 (18) 21 (17) 48(18)
60–69 17 (11) 19 (16) 36 (13)
70+ 16(11) 15(12) 31(11)
Time since last influenza vaccination
,1 year 6 (4) 11 (9) 0.02 17(6)
1 year 1 (1) 3 (2) 4 (1)
2–5 years 6 (4) 2 (2) 8 (3)
.5 years 19 (13) 6 (5) 25 (9)
Never 100 (66) 72 (59) 172 (63)
Unsure/Unknown 19 (13) 26 (21) 45 (16)
Symptoms in Past Month
Fever 5 (3) 6 (5) 0.49 11 (4)
ILI 3 (2) 4 (3) 0.73 7 (3)
P-values are based on a chi-squared test for differences between the
distribution of those who did and did not provide a blood sample. Only those
who provided a sample are included in the present analysis.
doi:10.1371/journal.ppat.1002802.t001
Author Summary
The human immune response to an influenza infection is
not the same for every infection. It has often been
observed that we tend to have the highest antibody titer
(and presumably our strongest immune response) against
strains of influenza that we were exposed to early in life. In
this study, we obtained blood samples from 151 people
between 7 and 81 years of age and tested the samples for
the concentration of antibodies to many different (H3N2)
strains. We chose strains according to when they first
circulated, starting with a strain isolated just after the 1968
pandemic and going all the way through to very recent
strains. We found that a participant’s age at the time a
strain first circulated was very predictive of the strength of
their antibody against that strain. Not just for the first
strain they were likely to have seen, but also for the
second, third and all subsequent strains circulating during
their lifetime. This suggests to us that antibody titers to
influenza A H3N2 follow a pattern of antigenic seniority,
suggesting that we produce progressively fewer specific
antibodies to each subsequent infection as we age.
Antigenic Seniority of Influenza A H3N2
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age at time of testing. To test the hypothesis that there is a
common relationship between titer and age, we compared
generalized additive models where (A) the relationship between
neutralization titer and age is dependent only on the age at time of
strain isolation and age at time of testing (relative BIC 0.0) and (B)
the relationship between neutralization titer and age (at time of
testing) is unique to each strain (relative BIC 206.4). Based on BIC
we found model A to be the best model of neutralization titers, and
the performance of models A and B was roughly equivalent on
other metrics (AICc, performance on held out data, performance
of bootstrapped models). We considered two additional general-
ized additive models that capture the possible role of inherent
inter-individual variation in antibody response: (C) a model where
each individual has a random intercept and there is a common
effect of age at time of strain isolation (relative BIC 542.9) and (D)
a model with individual random intercepts and a strain specific
effect of age (relative BIC 654.3). While these models are inferior
to model A if compared by BIC, they are superior in other
measures of model fit (AICc and mean square error from cross
validation). However, unlike models A and B, these models cannot
be used to predict the titers of individuals outside of the training
set. For all models the residuals for log-titers were normally
distributed with a standard deviation of approximately one (1.15
for model A, 0.91 for model D) (Figure S3).
Based on its superior BIC and its otherwise equivalent
performance to model B, we take model A as the primary model
for the remaining analysis. We will refer back to the individual
intercept models (C and D) when appropriate.
The effects of strain and age on neutralization titer
Decomposing the three components of model A (titer by age at
time of testing, by age at time of strain isolation and the strain
specific intercept) illustrates the effect each of these components
has on mean log neutralization titer (Figure 3). Age at testing has
little effect on neutralization titer until around age 60, at which
point neutralization titers increase smoothly with age (Figure 3A).
Age at time of strain isolation causes the largest variation in
neutralization titers, with titers peaking at 7 years of age (increase
in log titer of 3.4 over baseline, 95% CI, 2.4–4.5) and declining
smoothly thereafter (Figure 3B). Those born 10 or more years after
a strain was first isolated had the lowest titers to that strain, with
increasing titers in those born shortly after or shortly before strain
isolation until the 7 year peak. Even after adjusting for the effect of
age at time of testing and age at time of isolation there is still
variation in titer between tested strains of H3N2, with the highest
neutralization titers being seen against A/Fujian/2002 (H3N2)
and the lowest against A/Victoria/1975 (H3N2) (Figure 3C).
Visual comparison of predictions from this model with log
neutralization titer by age at time of isolation show substantial
agreement, and confirm the strain independent relationship
between age and titer (Figure 1).
Examination of each individual’s neutralization titer against
each tested strain gives further evidence of age-specific patterns in
neutralization titers and strain-to-strain variation (Figure 4). Some
strains have a very low rate of detectable titers in some age groups.
For instance, only 41% of those 50–69 years show neutralization
titers 1:10 (18/44) or higher to A/Beijing/1989. In contrast, 82%
(36/44) had titers of 1:10 or higher to A/Bangkok/1979 (the
previous chronological strain among those tested), and 82% (36/
44) had titers of 1:10 or higher to A/Wuhan/1995 (the next
chronological strain among those tested).
Despite the importance of age in predicting neutralization titers,
individual deviations were common, perhaps attributable to
differences in exposure history (Figure 4). For instance, those
60–69 years old generally have undetectable titers (,1:10) to
H3N2 strains isolated 2003 or later, but two individuals (from
separate study sites) have high titers to these strains. In model C we
account for individuals with generally high or low neutralization
titers, strain to strain variation and the age at time of strain
isolation; still, 7.7% of measured titers are at least four times
higher than predicted and 7.1% are at least four times lower.
Models with individuals intercepts outperform other models on
metric that do not penalize extra parameters as aggressively as
BIC, indicating a possible role for inherent individual variation in
antibody response or frequency of influenza exposure not captured
by other covariates. However, the maximally complex model has
similar performance to the far simpler model A throughout much
of the data (Figure S4).
Comparison with models of Original Antigenic Sin
We compared the performance of model A with models
capturing the hypothesis of original antigenic sin. In these models
titer depends on a strain intercept and antigenic distance from the
first strain in our data that circulated in each participant’s lifetime
(as measured in by Smith et al., 2004 [12]). Of the models
considered (see Supplemental Text S1) the best model of original
antigenic sin treated antigenic distance as a linear term and
included a terms for whether the participant was alive when the
strain circulated. Despite the relative simplicity of this model, this
model was out performed by model A in terms of BIC (relative
BIC= 34.3). Models of original antigenic sin fit titers for strains
circulating before birth well, suggesting that log-neutralization titer
decreases by approximately 0.1 log for every unit of antigenic
distance from the first possible infecting strain.
Sensitivity analyses and model validation
Because of missing low vaccination rates and the frequency of
missing vaccination status (Table S2), we did not consider
vaccination as a covariate in the main analysis. Only 32 of the
151 individuals in our study reported ever having received an
influenza vaccination and, of these, only 13 reported receiving
vaccination within the last 5 years (Table S2). We performed
additional analyses to assess the possibility that vaccination
confounded our results. First, we refitted the models using data
only from those who reported having never received a vaccination
(n= 100) (Figure S5). Second, we refitted the models with an
additional binary term for the subset of participants who reported
whether or not they had ever received a vaccination (n= 132).
Third, on the same subset, we included an additional categorical
term capturing the full range of reported vaccination histories
(n = 132). None of these analyses produced qualitatively different
results.
We performed several tests of model generalizability. First we
performed cross validation leaving each titer out from the training
Figure 1. Neutralization titers to strains of H3N2 from 1968 to 2008 by age at time of testing (left) and age at time of isolation of
each of the viruses tested (right) (i.e., the right panel shows values in the left panel age shifted by year of strain circulation). Purple
lines show smoothed results (LOESS curves, span= 0.25, Gaussian distribution family). Orange lines and shaded regions show predictions and 95%
confidence intervals from a log-linear model of neutralization titers where the effect of age at time of isolation and age at time of testing is the same
across strains.
doi:10.1371/journal.ppat.1002802.g001
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data in turn, and then predicting that value using a model fit to the
remaining data. Model A performed similarly on cross validated
data as to models fit to the full data, while models B, C and D
showed small increase in mean squared error (MSE) (Table S1).
Second, we fit 500 models to separate bootstrap datasets and used
these models to predict on the original data (a technique that is not
valid for the individual intercept models, C and D); MSE for the
bootstrapped models was similar to that seen when fitting and
predicting on the full data (Table S1).
Third, we fit model A with titers for each strain left out in turn.
We found that the relationship between titer and age was
qualitatively similar regardless of which strain was held out, with
Figure 2. The relationship between birth cohort and mean log titer. (A) Geometric mean of neutralization titer for each strain by birth cohort.
Points are only shown if more than half of the birth years in the indicated range occurred after strain isolation (i.e., most of that cohort was alive to be
exposed to the given strain). (B) Relative mean log-titer of the given birth cohort compared to all those old enough to be exposed to the given strain.
Note that the pattern of increasing maximum titer by birth cohort is a result of the larger pool of individuals with which they are compared (e.g., the
,1968 birth cohort is only compared with itself for A/Hong Kong/1968, while the 1978–1987 cohort is compared to all of those born before 1989 for
A/Beijing/1989). Points are only shown if more than half of the birth years in the indicated range occurred after strain isolation.
doi:10.1371/journal.ppat.1002802.g002
Figure 3. Statistical model of neutralization titers. Strains have shared distributions for the effect of (A) age at time of testing (range 10 to 80,
data ranges from 7 to 81) and (B) age at the time when the given strain was isolated (range 230 to 80, data range 234 to 80). Each strain has an
independent intercept (C). Relative log titers show the linear change in log neutralization titers compared to the model prediction for the (A) lowest
age at time of testing, (B) lowest age at time of strain isolation and (C) A/Hong Kong/1968 (the first strain isolated).
doi:10.1371/journal.ppat.1002802.g003
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the exception of the model fit without A/Hong Kong/1968
(Figure S6). In addition to A/Hong Kong/1968’s unique position
in our data (it is the first pandemic strain), the model fit excluding
this strain does not generalize well to predicting A/Hong Kong/
1968 titers and does not increase model fit to other strains (Table
S3). For all other strains, the reduced models perform well in
predicting the titers of the held out strain, resulting in an increase
in mean squared error of 10% or less (Table S3).
Finally, we fit model A with observations for each of the five
locations left out in turn. We found that the relationship between
titer and age was qualitatively similar regardless of which location
was held out, and that the model predicted well on the held out
locations (Table S4).
Discussion
In this study we have demonstrated a clear relationship between
the age at first potential exposure to a strain of influenza A (H3N2)
and an individual’s neutralization titer to that strain. Using robust
statistical techniques, we have demonstrated that this age
dependence is consistent across strains. Titers are highest against
strains circulating when individuals are 5–10 years of age, and
then decline steadily thereafter. Independent of strain and age at
first potential exposure, titers start to rise after age 60 at time of
testing.
The clinical and epidemiological implications of this phenom-
enon depend on the mechanism leading to these differences.
Several plausible options present themselves: immune boosting
and interference, age dependent patterns of exposure and changes
in the immune system as we age. Immunologic boosting and
interference, the tendency for later infections to boost antibody
levels to earlier infecting strains and for antibodies to earlier
infecting strains to mitigate the later immune response, has
historically received the most attention and is supported by
experimental evidence [4,5,12,13]. However, it seems that age-
specific patterns of influenza infection must also play a role. We
observe numerous deviations from the age-specific patterns of
neutralization titers that are most easily explained by differences in
exposure; and the relationship between age at time of circulation
and neutralization titer observed is remarkably similar to the
pattern of infection predicted in studies of social contact and
mixing patterns [14]. Regardless of the mechanism, it is evident
that there remains substantial individual variation in neutralization
titer not explained by any of the models considered. This is not
unexpected as influenza infection and immune response are
influenced by stochastic events which will not be captured by any
model.
The peak in neutralization titers to strains circulating when a
child is around seven years of age is consistent with recent work
showing that children in the Netherlands are infected with at least
one strain of influenza A by age seven [15], particularly if (as
suggested by the hypothesis of original antigenic sin) the antibody
response elicited by this first infection is greater than that elicited
by later infections. However, it seems that the patterns observed
here are not merely the primacy of the first infecting strain (i.e.,
original antigenic sin) plus cross-reactivity, as we would then
expect that the relationship between age at time of strain isolation
and antibody titer would be symmetric around the peak (such an
interpretation would also be inconsistent with the experimental
results of St Groth et al. [4]). However, there is some reactivity to
particular strains among those who were not yet born when the
strain circulated. For instance, some individuals born 10 years or
more after A/Hong Kong/1968 circulated have titers 1:20 or
greater to that strain. The extent to which those who were not yet
born respond to an earlier strain must represent the antigenic
similarity between that strain and the ones they were exposed to.
While some studies of immune response post-vaccination
suggest that the inhibiting effects of earlier exposures on the
production of vaccine strain specific antibodies may have been
overstated, [7] the results of numerous population based and
experimental studies (including our own) consistently show
evidence of an elevated response to the first strains (potentially)
encountered. [2–4,16] Additional laboratory experiment and
observational work is needed to resolve these discrepancies.
The mechanism behind the apparent increase in antibody titer
with age among those over 60 years old at time of testing is
unclear. Particularly interesting is the fact that this phenomena is
evident in response to strains circulating when these individuals
were young, middle aged and old; hence it is unlikely to be
explained solely by increased exposure in older individuals.
Increased longevity among those with high antibody titers
(survivor bias), or the effect of having lived through two influenza
pandemics prior to 2009 (60 year-olds would have been school
aged in 1957) are both plausible explanations. This former
hypothesis is not without precedent, a strong association between
higher antibody response and increased lifespan (with death due to
causes other than infection) has been observed in experimental
mouse models [17,18].
There are several possible reasons for the strain-to-strain
variation that remained even after age at time of testing and age
at first circulation is taken into account. These include differences
in the extent to which each strain circulated in the region, the
intrinsic ability of a specific strain to elicit an immune response,
and differences in the neutralizing ability of viral stocks generated
for the assays. While residual confounding of the relationship
between strain and age is possible, this relationship should be
captured by the spline term for age at time of strain isolation.
This study was conducted in five communities in one southern
province of China, where exposure histories are likely correlated.
Patterns of immune response seen here may be unique to the
region, though apparent similarities to historical work suggest that
this is not the case [1,2]. The youngest and oldest age groups are
poorly represented: hence, our results may not be generalizable to
young children and those over 80. At the extremes of the range of
ages seen in the data, the predicted relationship between titer and
age will be more sensitive to outliers and may be biased; however,
cross-validation results indicate this is likely not the case. Because
this was a cross sectional study, it is difficult to identify potential
mechanisms behind the pattern of neutralization response to
historic H3N2 strains. Knowing an individual’s history of
influenza infection would aid greatly in the interpretation of our
results, but such data requires long running longitudinal observa-
tions and is not available in the current cross sectional study. While
there may be some differences in the persistence of antibodies by
strain, robustness of a model where titer patterns are shared across
strains (model A) suggest this is not the case. However, there is
some indication of inter-individual variation that may be due to
different rates of antibody decay between individuals.
Understanding how serological presentation varies by age has
important implications for studies relying on sero-epidemiology. If
Figure 4. Heat-map of neutralization titers from all 151 individuals to each of the strains tested. Each individual’s titers are represented
as a row, and individuals are sorted from youngest (on bottom) to oldest (on top). Darker shading indicates a higher neutralization titer.
doi:10.1371/journal.ppat.1002802.g004
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we hope to measure variations in incidence between populations,
it is important that we understand how differences in the age
composition of different populations affect observed titers. In
vaccine trials, where serological response is used as an immune
correlate, understanding the background patterns in influenza
serologies can improve the interpretation of results. To the extent
that neutralization titers are correlates of influenza immunity, they
may have clinical and public health implications. Age-specific
patterns of protection may indicate those groups that would
benefit most from vaccination or the use of a high antigen vaccine.
Correct estimates of age-specific patterns of protection can
improve simulation studies aimed at predicting the impact of
influenza infection.
The patterns observed here are similar to those observed by
Francis in the mid-20th century [1,2]. These earlier studies were
primarily focused on H1N1 and, to a lesser extent, H2N2
subtypes. Hence, the patterns seen here are not unique to H3N2
influenza. However, earlier authors did not have modern statistical
tools and were unable to characterize the phenomena in the same
detail as the present work. In addition, Francis and others were
primarily focused on the primacy of the first strain to which an
individual was exposed (true original antigenic sin), and did not
identify the importance of age at exposure to later strains.
We propose that the age dependence observed in this study is
more properly called ‘‘antigenic seniority’’ rather than ‘‘original
antigenic sin’’, as it is not only the first strain circulating in an
individual’s lifetime for which there is an elevated response. We
find evidence that the earlier in life that someone is potentially
exposed to a strain the higher their antibody titers are likely to be.
In the strict interpretation of original antigenic sin, the first
childhood influenza infection gains a privileged spot in the
immune response, muting the immune response to later viruses
and being boosted by later infections. [1] We hypothesize that
antigenic seniority may work in a similar manner: viruses to which
an individual is exposed early in life can be thought of as taking on
senior positions in the hierarchy of immune response, each
subsequent infection taking on the next most senior position. Later
infections both boost the antibody response to the more senior
virus and may have a lessened antibody response themselves. This
hypothesis is consistent with the patterns observed in the present
study and experimental evidence [3,12,13], though more recent
work has shown that multiple immunizations can produce a
broadly protective immune response [18–20]. Even if immune
boosting and inhibition are the predominant drivers of the
patterns seen, factors such as difference in influenza exposure by
age likely still play a role.
Materials and Methods
Ethics statement
All study protocols and instruments were approved by the
following institutional review boards: Johns Hopkins Bloomberg
School of Public Health, University of Liverpool, University of
Hong Kong, Peoples Number 12 Hospital Guangzhou, and
Shantou University. Written informed consent was obtained from
all participants over 12 years of age. Verbal assent was obtained
for participants of 12 years of age or younger. Written permission
of a legally authorized representative was obtained for all
participants under the age of 18.
Participant recruitment
Participants were enrolled from 100 randomly selected house-
holds from five study locations (20 per location) in a transect
extending to the northeast from Guangzhou, China, as described
in Lessler et al [21]. All household members over two years of age
were eligible to participate. Household members agreeing to
participate were administered informed consent and offered two
levels of participation: (1) completing a questionnaire and (2)
completing the questionnaire and providing a blood sample.
Enrollment ran from July 8, 2009 to September 21, 2009.
Strain selection
Nine strains of influenza A (H3N2) spanning the history of the
virus from its emergence in 1968 until the present were selected for
serological testing (Figure S7). We chose six vaccine strains from
every second antigenic cluster, starting with a Hong Kong 1968
[10]: A/Hong Kong/1/1968 (H3N2), A/Victoria/3/1975
(H3N2), A/Bangkok/1/1979 (H3N2), A/Beijing/353/1989
(H3N2), A/Wuhan/359/1995 (H3N2) and A/Fujian/411/2002
(H3N2). In addition, three recently circulating H3N2 viruses
isolated in southern China were selected for testing: A/Shantou/
90/2003, A/Shantou/806/2005 and A/Shantou/904/2008.
Shantou strains are genetically similar to contemporaneous
vaccine strains, and may be presumed to be in same antigenic
cluster as these viruses (see Figure S7).
Serological assays
Hemagglutination inhibition (HI) and virus neutralization (NT)
assays were performed for each of the nine selected strains of
influenza A (H3N2) as described in Lessler et al. [21] Antibody
titers were determined by testing serial two-fold dilutions from
1:10 to 1:1280 in duplicate (uncertain results were resolved by
repeated testing in quadruplicate). Positive and negative control
sera were also tested. The highest dilution resulting in complete
protection of the cell monolayer in more than two of the
quadruplicate wells (or both duplicate wells) was regarded as the
antibody titer.
Analysis
The effects of both participant age at time of testing and
participant age in the year of strain isolation on NT titers were
considered. In all cases serological results were assumed to be
exact and participants with undetectable titers (,1:10) were
assumed to have a titer of 1:5. Models capturing two hypotheses
were compared: (A) the age dependency of serological response is
common across strains and based only on the age at time of testing
and age at time of strain isolation, and (B) the age dependency of
serological response is strain specific. Generalized additive models
representing each hypothesis were fit to log-neutralization data
and compared using Bayesian information criteria (BIC) [22,23].
Generalized additive models provide a flexible and integrated
framework for fitting non-linear relationships between data (i.e.,
models with a spline term). [23] BIC heavily favors more
parsimonious models, and we selected it as the primary
comparison criteria to avoid over-fitting. However, we also
compare models on the basis of other information based and
cross-validation based criteria (e.g., cross-validated MSE and
AICc). Confidence intervals in figures were created from standard
errors calculated using the mgcv package in R, which are based
upon the Bayesian posterior covariance matrix [23].
All analyses were repeated using HI titers yielding qualitatively
identical results (Figure S8). Details of statistical models are
available in supplemental Text S1. Data used in this analysis is
available in Dataset S1.
All statistical analyses were performed using the R statistical
package (R 2.11, www.cran.org).
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Supporting Information
Dataset S1 Individual-level data used in the analyses presented
in this paper. The file contains 1,359 records for: age, age of the
participant at time of sampling; is.vac, the number of years
previously that the person has been vaccinated (1 for this year,
greater than 1 year up to 2 years ago, 3 for 3 years ago, 4 for 4
years ago and 5 for 5 or more years ago, NA where the question
was not answered); shift.age, the age of the participant in the year
that the strain in question first circulated; titers, the neutralization
titer against the strain in question; neut.against, the strain against
which the titer is measured and for which shift.age is calculated; id,
a unique study id for the analysis presented in here; and loc, a
unique study id for the analysis presented here.
(CSV)
Figure S1 Box-plots of neutralization titers to strains of H3N2
from 1968 to 2008 by age at time of testing (left) and age at time of
isolation of each of the viruses tested (right). Filled circles indicate
medians, boxes indicate the inter-quartile range, whiskers
indicate+/21.5 inter-quartile ranges and open circles indicate
outliers.
(EPS)
Figure S2 Heat map of the proportion of individuals at a given
age at the time of testing having neutralization titers of the given
value.
(PDF)
Figure S3 Analysis of model residuals, checking for normality
and systematic patterns of bias. Red lines pass through first and
third quantiles. Solid black lines indicate the mean of the residuals,
dashed black lines are placed at+/2one standard deviation, and
blue lines show LOESS curve fits to the residuals.
(PDF)
Figure S4 Comparison of residuals in a model with only age
effects and a strain intercept (model A) versus a model with
individual intercepts and strain specific age effects (model D),
comparing the mean trend (blue line) with equality (black line). For
most predictions model D does not systematically outperform
model A, and they have similar error structures.
(PDF)
Figure S5 Model with shared age effects and strain intercepts
(model A) fit to only those individuals reporting that they never
have been vaccinated.
(PDF)
Figure S6 Model components with the titers to the indicated
strain left out of the fitting process. Shaded areas indicate the 95%
confidence interval on the spline terms from the full model. Strains
have shared distributions for the effect of (A) age at time of testing
(range 10 to 80, data ranges from 7 to 81) and (B) age at the time
when the given strain was isolated (range 230 to 80, data range
234 to 80). Each strain has an independent intercept (C).
(PDF)
Figure S7 Timeline and genetic distance of H3N2 viruses
selected for testing (in blue), and other antigenically representative
H3N2 viruses (in black). Genetic distance was measured using
Kimura’s 2-parameters distance rescaled to a single dimension
using multi-dimensional scaling. [24,25]
(PDF)
Figure S8 Strain independent model results for HI titers. Strains
have shared distributions for the effect of (A) age at time of testing
(range 10 to 80, data ranges from 7 to 81) and (B) age at the time
when the given strain was isolated (range 230 to 80, data range
234 to 80). Each strain has an independent intercept (C).
(PDF)
Table S1 Characteristics and performance of models of titer
response, including effective degrees of freedom (DF), log-
likelihood, Bayesian information criteria (BIC), corrected Akaike
information criteria (AICc), mean squared error on the fit data
(MSE), hold-one-out cross validated MSE, and bootstrapped
average MSE (500 bootstrap iterations). Models were fit using the
mgcv package in the R statistical language. In the strain
independent model (A), smooth functions of age at time of testing
and age at time of strain circulation were modeled as having a
common effect across all strains. In the strain dependent model
(B), each strain is allowed an independent relationship with a
smooth function of time at testing. The random intercept model
(C) extends the strain independent model, allowing each individual
to have an independent intercept. The random intercept model
strain dependent model (D) extends the strain dependent model in
the same way. Models A–D allow strain specific intercepts. Bias
was within 0.005 of 0 in all tests.
(DOCX)
Table S2 Time since last vaccination versus age. While the
majority of individuals have never been vaccinated in most age
groups, the relationship between time since vaccination and age is
significant (simulated Chi-squared p= 0.031).
(DOCX)
Table S3 Changes in model performance after holding out each
strain from the fitting process in turn. The held out strain bias and
mean squared error (MSE) is calculated by predicting strain titers
for the held out strain using the intercept for that strain in the full
model and the ‘‘age at time of testing’’ and ‘‘age at time of strain
isolation’’ spline terms from the model fit without that strain (i.e.,
using the shape from the reduced model shifted by the strain
specific intercept). Full models were obtained by calculating the
MSE using residuals only from those observations included in the
comparison set. While holding out A/Hong Kong/1968 results in
a model that has poor performance on that strain, its inclusion
does not substantively reduce model fit to other strains.
(DOCX)
Table S4 Changes in model performance after holding out each
location from the fitting process in turn.
(DOCX)
Text S1 Additional details for statistical methods.
(DOCX)
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